Solving the opioid epidemic requires a “whole person” approach that includes nonpharmacological treatment for pain, as well as ensuring that people have the employment, education and housing supports they need for long-term recovery, the chief executive officer of the American Psychological Association (APA) told a congressional panel.

The opioid overdose epidemic continues to claim lives across the country with a record 47,600 overdose deaths in 2017[i]. The crisis is taking an especially devastating toll on certain parts of the U.S. workforce. High rates of opioid overdose deaths have occurred in industries with high injury rates and physically demanding working conditions such as construction, mining, or fishing[ii],[iii].

The National Institutes of Health (NIH) is warning of a “converging public health crisis,” as the nation’s opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections. Infectious disease and substance use disorder professionals must work together to stem the mounting public health threat, according to a new commentary in the Journal of Infectious Diseases.

The Travelers Companies, Inc. reports that it has reduced opioid use by nearly 40 percent among the injured construction workers it has helped, thanks in part to the Early Severity Predictor® model, which helps predict which injured employees are at higher risk of experiencing chronic pain. Additionally, the insurance giant implemented a comprehensive pharmacy management program that monitors drug interactions, excessive dosing and abuse patterns to reduce the risk of opioid dependency.

The National Institutes of Health (NIH) has begun testing an experimental drug that could help opioid addicts deal with the cravings that cause them to continue using the dangerous substance. In Phase I of the clinical trial currently underway at the NIH Clinical Center – researchers will study how the compound ANS-6637 is processed in the body when given with another drug that is processed by the same liver enzyme pathway.

Although numerous reports attribute fentanyl overdose deaths to illegally manufactured versions of the drug, new research shows that pharmaceutical fentanyl may be playing a significant role in the opioid crisis. The study, presented this week at the American Public Health Association’s 2018 Annual Meeting and Expo found that 44 percent of people who died from fentanyl overdose had previously been prescribed fentanyl by a medical professional.

People who were exposed to the terrorist attacks at the World Trade Center (WTC) have elevated rates of alcohol- or drug-related death, reports a study in the October issue of the Journal of Occupational and Environmental Medicine. "Following a major disaster, alcohol- and drug-related mortality may be increased," according to the new research by Jim Cone, MD, and colleagues of the New York City Department of Health and Mental Hygiene.

Senator Ted Cruz (R-TX) joined NSC President and CEO, Deborah Hersman, for a press unveiling of the Prescribed to Death opioid memorial on Monday at the National Safety Council Congress & Expo in Houston. The memorial has been touring the country since last November, stopping in Chicago, Pittsburgh, Atlanta, Buffalo, N.Y., Fayetteville Ark., and Washington, D.C., where it sat on the South Lawn of the White House.

Sales of JUUL, an e-cigarette shaped like a USB flash drive, grew more than seven-fold from 2016 to 2017, and held the greatest share of the U.S. e-cigarette market by December 2017. The findings, from an analysis of retail sales data from 2013-2017, were released today by the Centers for Disease Control and Prevention (CDC) in JAMA.

One out of every 12 adults in the United States suffers from alcohol dependence, making alcohol the most regularly used addictive substance in America, the National Council on Alcoholism and Drug Dependence (NCADD) reports.